These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 24009738)
1. The role of phospholipase D in modulating the MTOR signaling pathway in polycystic kidney disease. Liu Y; Käch A; Ziegler U; Ong AC; Wallace DP; Arcaro A; Serra AL PLoS One; 2013; 8(8):e73173. PubMed ID: 24009738 [TBL] [Abstract][Full Text] [Related]
2. The role of phospholipase D and phosphatidic acid in the mechanical activation of mTOR signaling in skeletal muscle. Hornberger TA; Chu WK; Mak YW; Hsiung JW; Huang SA; Chien S Proc Natl Acad Sci U S A; 2006 Mar; 103(12):4741-6. PubMed ID: 16537399 [TBL] [Abstract][Full Text] [Related]
3. Reciprocal regulation of AMP-activated protein kinase and phospholipase D. Mukhopadhyay S; Saqcena M; Chatterjee A; Garcia A; Frias MA; Foster DA J Biol Chem; 2015 Mar; 290(11):6986-93. PubMed ID: 25632961 [TBL] [Abstract][Full Text] [Related]
4. Phospholipase D signaling in serotonin-induced mitogenesis of pulmonary artery smooth muscle cells. Liu Y; Fanburg BL Am J Physiol Lung Cell Mol Physiol; 2008 Sep; 295(3):L471-8. PubMed ID: 18621911 [TBL] [Abstract][Full Text] [Related]
5. Activation of AMPK/TSC2/PLD by alcohol regulates mTORC1 and mTORC2 assembly in C2C12 myocytes. Hong-Brown LQ; Brown CR; Navaratnarajah M; Lang CH Alcohol Clin Exp Res; 2013 Nov; 37(11):1849-61. PubMed ID: 23895284 [TBL] [Abstract][Full Text] [Related]
6. Phospholipase D and the maintenance of phosphatidic acid levels for regulation of mammalian target of rapamycin (mTOR). Foster DA; Salloum D; Menon D; Frias MA J Biol Chem; 2014 Aug; 289(33):22583-22588. PubMed ID: 24990952 [TBL] [Abstract][Full Text] [Related]
7. Regulation of mTORC1 and mTORC2 complex assembly by phosphatidic acid: competition with rapamycin. Toschi A; Lee E; Xu L; Garcia A; Gadir N; Foster DA Mol Cell Biol; 2009 Mar; 29(6):1411-20. PubMed ID: 19114562 [TBL] [Abstract][Full Text] [Related]
8. Phospholipase D regulates the size of skeletal muscle cells through the activation of mTOR signaling. Jaafar R; De Larichaudy J; Chanon S; Euthine V; Durand C; Naro F; Bertolino P; Vidal H; Lefai E; Némoz G Cell Commun Signal; 2013 Aug; 11():55. PubMed ID: 23915343 [TBL] [Abstract][Full Text] [Related]
9. Ca(2+)- and phospholipase D-dependent and -independent pathways activate mTOR signaling. Ballou LM; Jiang YP; Du G; Frohman MA; Lin RZ FEBS Lett; 2003 Aug; 550(1-3):51-6. PubMed ID: 12935885 [TBL] [Abstract][Full Text] [Related]
10. Phospholipase D1 is an effector of Rheb in the mTOR pathway. Sun Y; Fang Y; Yoon MS; Zhang C; Roccio M; Zwartkruis FJ; Armstrong M; Brown HA; Chen J Proc Natl Acad Sci U S A; 2008 Jun; 105(24):8286-91. PubMed ID: 18550814 [TBL] [Abstract][Full Text] [Related]
11. Phospholipase D2-derived phosphatidic acid binds to and activates ribosomal p70 S6 kinase independently of mTOR. Lehman N; Ledford B; Di Fulvio M; Frondorf K; McPhail LC; Gomez-Cambronero J FASEB J; 2007 Apr; 21(4):1075-87. PubMed ID: 17242159 [TBL] [Abstract][Full Text] [Related]
12. Regulation of phospholipase D activity and phosphatidic acid production after purinergic (P2Y6) receptor stimulation. Scott SA; Xiang Y; Mathews TP; Cho HP; Myers DS; Armstrong MD; Tallman KA; O'Reilly MC; Lindsley CW; Brown HA J Biol Chem; 2013 Jul; 288(28):20477-87. PubMed ID: 23723068 [TBL] [Abstract][Full Text] [Related]
13. 5-Aminosalicylic acid inhibits cell cycle progression in a phospholipase D dependent manner in colorectal cancer. Baan B; Dihal AA; Hoff E; Bos CL; Voorneveld PW; Koelink PJ; Wildenberg ME; Muncan V; Heijmans J; Verspaget HW; Richel DJ; Hardwick JC; Hommes DW; Peppelenbosch MP; van den Brink GR Gut; 2012 Dec; 61(12):1708-15. PubMed ID: 22187071 [TBL] [Abstract][Full Text] [Related]
14. Sustained PKCβII activity confers oncogenic properties in a phospholipase D- and mTOR-dependent manner. El Osta M; Liu M; Adada M; Senkal CE; Idkowiak-Baldys J; Obeid LM; Clarke CJ; Hannun YA FASEB J; 2014 Jan; 28(1):495-505. PubMed ID: 24121461 [TBL] [Abstract][Full Text] [Related]
16. Morphoproteomic analysis reveals an overexpressed and constitutively activated phospholipase D1-mTORC2 pathway in endometrial carcinoma. Shen Q; Stanton ML; Feng W; Rodriguez ME; Ramondetta L; Chen L; Brown RE; Duan X Int J Clin Exp Pathol; 2010 Nov; 4(1):13-21. PubMed ID: 21228924 [TBL] [Abstract][Full Text] [Related]
17. The PI3K/Akt/mTOR pathway in polycystic kidney disease: A complex interaction with polycystins and primary cilium. Margaria JP; Campa CC; De Santis MC; Hirsch E; Franco I Cell Signal; 2020 Feb; 66():109468. PubMed ID: 31715259 [TBL] [Abstract][Full Text] [Related]
18. A study of sirolimus and mTOR kinase inhibitor in a hypomorphic Holditch SJ; Brown CN; Atwood DJ; Lombardi AM; Nguyen KN; Toll HW; Hopp K; Edelstein CL Am J Physiol Renal Physiol; 2019 Jul; 317(1):F187-F196. PubMed ID: 31042058 [TBL] [Abstract][Full Text] [Related]
19. Phosphatidic acid signaling to mTOR: signals for the survival of human cancer cells. Foster DA Biochim Biophys Acta; 2009 Sep; 1791(9):949-55. PubMed ID: 19264150 [TBL] [Abstract][Full Text] [Related]
20. The role of diacylglycerol kinase ζ and phosphatidic acid in the mechanical activation of mammalian target of rapamycin (mTOR) signaling and skeletal muscle hypertrophy. You JS; Lincoln HC; Kim CR; Frey JW; Goodman CA; Zhong XP; Hornberger TA J Biol Chem; 2014 Jan; 289(3):1551-63. PubMed ID: 24302719 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]